\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\\.\ \(14\)\
\-\ follow\\-up\\ ct\\ in\\ 6\\ months\\ and\\ correlation\\ with\\ laboratory\\ values\\ to\\ ensure\\ no\\ evidence\\ of\\ hyperfunction\\.\ \(0\)\
\-\ an\\ unenhanced\\ axial\\ ct\\ image\\ through\\ the\\ upper\\ abdomen\\ demonstrates\\ an\\ incidentally\\ noted\\ round\\,\\ homogeneous\\ noncalcified\\ mass\\ arising\\ from\\ the\\ right\\ adrenal\\ gland\\.\\ \\ the\\ hounsfield\\ units\\ within\\ this\\ right\\ adrenal\\ mass\\ measured\\ 7\\,\\ consistent\\ its\\ representing\\ a\\ lipid\\-rich\\ adenoma\\.\ \(0\)\
\-\ adrenal\\ adenoma\ \(7\)\
\-\ differential\\ diagnosis\\ of\\ an\\ adrenal\\ mass\\:\ \(0\)\
\-\ adrenal\\ adenoma\ \(7\)\
\-\ adrenal\\ carcinoma\ \(2\)\
\-\ pheochromocytoma\ \(23\)\
\-\ adrenal\\ metastasis\\ and\\ lymphoma\ \(0\)\
\-\ myelolipoma\ \(12\)\
\-\ adrenal\\ cyst\ \(0\)\
\-\ a\\ 40\\ year\\ old\\ male\\ with\\ a\\ suspected\\ \\"infiltrate\\"\\ seen\\ on\\ chest\\ radiographs\\.\\ \\ a\\ chest\\ ct\\ was\\ performed\\ after\\ follow\\-up\\ chest\\ radiographs\\ failed\\ to\\ show\\ resolution\\.\ \(0\)\
\-\ according\\ to\\ an\\ nih\\ consensus\\ statement\\,\\ a\\ mass\\ that\\ is\\ stable\\ on\\ imaging\\ examinations\\ seperated\\ by\\ at\\ least\\ six\\ months\\ and\\ that\\ demonstrates\\ no\\ evidence\\ of\\ hyperfunction\\ over\\ 4\\ years\\ needs\\ no\\ further\\ follow\\-up\\.\ \(0\)\
\-\ management\\ of\\ the\\ clinically\\ inapparent\\ adrenal\\ mass\\ \\(\\"incidentaloma\\"\\)\\.\\ nih\\ consens\\ statement\\ online\\ 2002\\ feb\\ 4\\-6\\;19\\(2\\)\\:1\\-23\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adrenal\\:\\ 0\\.6224755790897823\ \(0\)\
\-\ hyperfunction\\:\\ 0\\.23885727075524854\ \(0\)\
\-\ statement\\:\\ 0\\.214865795596467\ \(0\)\
\-\ adenoma\\:\\ 0\\.17861466045485322\ \(0\)\
\-\ nih\\:\\ 0\\.14894430334645656\ \(0\)\
\-\ mass\\:\\ 0\\.14262770641414\ \(0\)\
\-\ consens\\:\\ 0\\.11942863537762427\ \(0\)\
\-\ chest\\:\\ 0\\.1182587317455179\ \(0\)\
\-\ an\\:\\ 0\\.11422862380850325\ \(0\)\
\-\ incidentaloma\\:\\ 0\\.11412043693659403\ \(0\)\
\-\ inapparent\\:\\ 0\\.11035421020594888\ \(0\)\
\-\ seperated\\:\\ 0\\.1074328977982335\ \(0\)\
\-\ noncalcified\\:\\ 0\\.0997378133238884\ \(0\)\
\-\ online\\:\\ 0\\.09711070718944764\ \(0\)\
\-\ radiographs\\:\\ 0\\.09687214953457621\ \(0\)\
\-\ consensus\\:\\ 0\\.09395350320707795\ \(0\)\
\-\ myelolipoma\\:\\ 0\\.090663388152213\ \(0\)\
\-\ hounsfield\\:\\ 0\\.0886453047660477\ \(0\)\
\-\ months\\:\\ 0\\.08693891773813334\ \(0\)\
\-\ feb\\:\\ 0\\.08584927205305735\ \(0\)\
\-\ ct\\:\\ 0\\.08529345834946779\ \(0\)\
\-\ evidence\\:\\ 0\\.0847762906834339\ \(0\)\
\-\ pheochromocytoma\\:\\ 0\\.08441967552359336\ \(0\)\
\-\ needs\\:\\ 0\\.08354657684490367\ \(0\)\
\-\ unenhanced\\:\\ 0\\.08158896298053762\ \(0\)\
\-\ examinations\\:\\ 0\\.08158896298053762\ \(0\)\
\-\ infiltrate\\:\\ 0\\.07926282707105596\ \(0\)\
\-\ units\\:\\ 0\\.07896185684609686\ \(0\)\
\-\ ensure\\:\\ 0\\.07782273624989247\ \(0\)\
\-\ failed\\:\\ 0\\.07534525035191797\ \(0\)\
\-\ according\\:\\ 0\\.0751214563861893\ \(0\)\
\-\ demonstrates\\:\\ 0\\.07503624767620985\ \(0\)\
\-\ correlation\\:\\ 0\\.07447215167322828\ \(0\)\
\-\ measured\\:\\ 0\\.07365365840506662\ \(0\)\
\-\ no\\:\\ 0\\.07285468375612035\ \(0\)\
\-\ 2002\\:\\ 0\\.07146664844035173\ \(0\)\
\-\ representing\\:\\ 0\\.07065324226306197\ \(0\)\
\-\ least\\:\\ 0\\.06902393448365322\ \(0\)\
\-\ values\\:\\ 0\\.06888539744278857\ \(0\)\
\-\ six\\:\\ 0\\.06708567834600512\ \(0\)\
\-\ homogeneous\\:\\ 0\\.06593655268382345\ \(0\)\
\-\ that\\:\\ 0\\.06481612725220949\ \(0\)\
\-\ incidentally\\:\\ 0\\.06362321531695277\ \(0\)\
\-\ clinically\\:\\ 0\\.06206077193985655\ \(0\)\
\-\ round\\:\\ 0\\.06119031296844348\ \(0\)\
\-\ suspected\\:\\ 0\\.06119031296844348\ \(0\)\
\-\ gland\\:\\ 0\\.06066507692660295\ \(0\)\
\-\ resolution\\:\\ 0\\.06059173427991147\ \(0\)\
\-\ the\\:\\ 0\\.05960499363031811\ \(0\)\
\-\ arising\\:\\ 0\\.059337321659010525\ \(0\)\
\-\ 19\\:\\ 0\\.05913945953214117\ \(0\)\
\-\ stable\\:\\ 0\\.05907416449307603\ \(0\)\
\-\ of\\:\\ 0\\.05845772046629884\ \(0\)\
\-\ to\\:\\ 0\\.05600911790588596\ \(0\)\
\-\ its\\:\\ 0\\.05525917931428533\ \(0\)\
\-\ management\\:\\ 0\\.055162203847205965\ \(0\)\
\-\ 40\\:\\ 0\\.05492286211356633\ \(0\)\
\-\ metastasis\\:\\ 0\\.05473449011266101\ \(0\)\
\-\ laboratory\\:\\ 0\\.054230021710587495\ \(0\)\
\-\ available\\:\\ 0\\.05066782448391793\ \(0\)\
\-\ right\\:\\ 0\\.04951862910436571\ \(0\)\
\-\ further\\:\\ 0\\.04863995296406744\ \(0\)\
\-\ differential\\:\\ 0\\.04852306265008068\ \(0\)\
\-\ image\\:\\ 0\\.047760227769645766\ \(0\)\
\-\ show\\:\\ 0\\.047408208285465464\ \(0\)\
\-\ and\\:\\ 0\\.04629475773982941\ \(0\)\
\-\ years\\:\\ 0\\.045777479433795454\ \(0\)\
\-\ abdomen\\:\\ 0\\.045566885699272204\ \(0\)\
\-\ on\\:\\ 0\\.04510892773315007\ \(0\)\
\-\ carcinoma\\:\\ 0\\.04466984803664296\ \(0\)\
\-\ lymphoma\\:\\ 0\\.04447621319401242\ \(0\)\
\-\ through\\:\\ 0\\.044454873942027635\ \(0\)\
\-\ performed\\:\\ 0\\.04418058322129709\ \(0\)\
\-\ axial\\:\\ 0\\.04313751315274681\ \(0\)\
\-\ cyst\\:\\ 0\\.04307979831337625\ \(0\)\
\-\ over\\:\\ 0\\.04152503556319092\ \(0\)\
\-\ consistent\\:\\ 0\\.04049289078851328\ \(0\)\
\-\ upper\\:\\ 0\\.03990752049146661\ \(0\)\
\-\ noted\\:\\ 0\\.039594914175536795\ \(0\)\
\-\ imaging\\:\\ 0\\.039246557617494064\ \(0\)\
\-\ diagnosis\\:\\ 0\\.038713277168797286\ \(0\)\
\-\ after\\:\\ 0\\.036228206318006856\ \(0\)\
\-\ seen\\:\\ 0\\.03515846186747157\ \(0\)\
\-\ within\\:\\ 0\\.03439503369739128\ \(0\)\
\-\ male\\:\\ 0\\.03325014640837373\ \(0\)\
\-\ by\\:\\ 0\\.03171320897153426\ \(0\)\
\-\ from\\:\\ 0\\.029659495830352097\ \(0\)\
\-\ not\\:\\ 0\\.029481654886062338\ \(0\)\
\-\ with\\:\\ 0\\.029246324470173873\ \(0\)\
\-\ at\\:\\ 0\\.02820735881742726\ \(0\)\
\-\ was\\:\\ 0\\.026026513970883333\ \(0\)\
\-\ this\\:\\ 0\\.02566119036393339\ \(0\)\
\-\ year\\:\\ 0\\.023014724049063847\ \(0\)\
\-\ old\\:\\ 0\\.022102101831538188\ \(0\)\
\-\ is\\:\\ 0\\.020451463977788586\ \(0\)\
\-\ in\\:\\ 0\\.018577813714517354\ \(0\)\
